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Available online 20 October 2016Human lymphoblast cells from a female patient diagnosed with Alzheimer's disease (AD) possessing the mis-
sense mutation TREM2 p.R47H were used to generate integration-free induced pluripotent stem cells (iPSCs)
employing episomal plasmids expressing OCT4, SOX2, NANOG, LIN28, c-MYC and L-MYC. The iPSCs retained
the TREM2mutation, andwere deﬁned as pluripotent based on (i) expression of pluripotent-associatedmarkers,
(ii) embryoid body-based differentiation into cell types representative of the three germ layers and (iii) the sim-
ilarity between the transcriptomes of the iPSC line and the human embryonic stem cell line H1 with a Pearson
correlation of 0.961.
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Resource details
Lymphoblast cells (Lymph4), derived from a 67-year-old AD patient
with the TREM2missensemutation, p.R47H, (Cuyvers et al., 2014)were
reprogrammed employing oriP/EBNA-1-based episomal plasmids ex-
pressing OCT4, SOX2, KLF4, C-MYC, L-MYC, LIN28 and a p53 shRNA.
Clone A and B of AD2-4 iPSC line were negative for EBNA-1 and oriP
(Fig. 1A). Pluripotency was conﬁrmed by (i) expression of OCT4,
SOX2, c-MYC, NANOG, TRA-1-60 and TRA-1-81 (Fig. 1B) and (ii) embry-
oid body (EB)-based spontaneous differentiation into cell types repre-
sentative of the three germ layers, namely ectoderm (Nestin, PAX6),
mesoderm (SMA – smooth muscle actin) and endoderm (SOX17) (Fig.
1C).
The DNA ﬁngerprint of AD2-4 iPSC line was identical to the parental
lymphoblast line Lymph4 (Fig.1D). Karyotype analysis was female (XX)
and both lines exhibited a normal diploid chromosomal content (Fig.
1E). As depicted in the Cluster Dendrogram (Fig. 1F), the transcriptomes
of the AD2-4 iPSCs and the embryonic stem cell line-H1, clusteredivecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Characterization of the iPSC line AD2-4. (A) Conﬁrmation ofmRNA expression of pluripotency-associated, oriP and EBNA-1 genes. NTC and control are the same as described in [Lab
Resource Article CR1 CNV iPSC lines]. NTC, non-template control; PosCo, control line with oriP and EBNA-1 detection. (B) Immunoﬂuorescence-based detection of human pluripotency-
associated proteins OCT4, SOX2, c-MYC, NANOG and surfacemarkers TRA-1-60 and TRA-1-81. Hoechst 33,258was used for the nuclei staining. Scale bar: 100 μm. (C) Embryoid body (EB)
formation was induced in AD2-4 iPSCs in vitro and analyzed by immunoﬂuorescence-based detection of different germ layer marker: ectoderm – Nestin, PAX6; mesoderm – α-smooth
muscle actin (SMA) and endoderm – SOX17. Scale bar: 25 μm. (D) Gel electrophoresis of DNA ﬁngerprinting PCR products. Genomic DNA was isolated from parental lymphoblast cells
Lymph4, AD2-4 iPSCs and embryonic stem cell line H1. DNA was ampliﬁed using PCR primers that ﬂank different genomic regions (D10S1214, D21S2055). (E) Karyotyping analysis of
parental lymphoblast Lymph4 and iPSC line AD2-4. Presence of female karyogram 46, XX. (F) Cluster Dendrogram of AD2-4 iPSC line and embryonic stem cell line H1 in comparison to
Lymph2 lymphoblast cells (AD2-2) (Schröter et al., 2016b). (G) Sequence trace of iPSCs AD2-4. The TREM2 heterozygous base substitution (indicated by the black arrow) results in
missense mutation p.R47H.
554 F. Schröter et al. / Stem Cell Research 17 (2016) 553–555together with a Pearson correlation of 0.961. The reprogramming pro-
cess did not alter the TREM2 missense mutation as demonstrated in
Fig. 1G.
Materials and methods
Ethic statements
The EBV-transformed lymphoblastoid cell line Lymph4, used for the
generation of the iPSC line AD2-4, was generated from peripheral bloodlymphocytes from a 67-year-old female donor diagnosed with
Alzheimer's disease. The research protocol was approved by the Ethics
Committee of the University Hospital Antwerp and the University of
Antwerp, Belgium.
Cell culture
The lymphoblast cell line Lymph4 (Cuyvers et al., 2014) was cul-
tured in RPMI1640 supplemented with 15% fetal bovine serum
(Invitrogen™), 1% Glutamax (Invitrogen™), 1% Sodium pyruvate
555F. Schröter et al. / Stem Cell Research 17 (2016) 553–555(Invitrogen™) and 1% Penicillin/Streptomycin (Invitrogen™) at 37 °C
and 5% CO2.
Derivation of the iPS cell line
Lymphoblast cells (Lymph4) were reprogrammed by nucleofection
of oriP/EBNA-1-based episomal plasmids (expressing OCT4, SOX2,
KLF4, L-MYC, LIN28 and a p53 shRNA) (Okita et al., 2011) at the
Biomedicum Stem Cell Center, University of Helsinki, Finland, (http://
research.med.helsinki.ﬁ/neuro/Otonkoski/core/default.html) as a ser-
vice. The iPSCs were cultured under feeder-free conditions on
Matrigel®-coated plates in E8 medium (Invitrogen™).
Polymerase chain reaction
RT-PCR to assess the expression levels of the transgene and endoge-
nous stem cell markers were carried out by the Biomediucm Stem Cell
Center, University of Helsinki, Finland.
Embryoid body formation
Embryoid body (EB) formation was carried out as described in
(Schröter et al., 2016b). In brief, after culturing of the iPSCs in ultra-
low attachment ﬂask (Corning) in FDTAmedium, the EBswere replated
onto gelatin-coated plates, again in FDTA medium lacking bFGF and
Dorsomorphin (Frank et al., 2012).
Immunocytochemistry
Immunocytochemistry was performed as described in (Schröter et
al., 2016b; Schröter et al., 2016a) except for the germ layers staining.
The following antibodies were used: rabbit anti-Nestin (Sigma Aldrich;
1:1000), mouse anti-PAX6 (SYSY, 1:1000), mouse anti-SMA (Cell Sig-
naling; 1:1000) and mouse anti-SOX17 (Novus Biological, 1:500). The
ﬂuorescent images obtained by an inverse ﬂuorescence microscope
LSM 700 (Carl Zeiss) and analyzed employing Adobe Photoshop soft-
ware (Adobe, USA).
Karyotype analysis
Karyotype analysis was evaluated and performed at the Institute of
Human Genetics and Anthropology, Heinrich-Heine-University,
Düsseldorf. Twenty-six and twenty-ﬁve metaphases were counted for
the parental lymphoblast line Lymph4 and the iPSC line AD2-4,
respectively.
DNA ﬁngerprinting
Genomic DNA was isolated according to the manufacturer protocol
from the lymphoblast line Lymph4, the AD2-4 iPSC line and the
human embryonic stem cell line (H1). The STR analysis was performed
by PCR ampliﬁcation with speciﬁc primers (Prigione et al., 2011; Wang
and Adjaye, 2011).Bidirectional Sanger sequencing
Genotyping of TREM2 p.R47Hwas performed on genomic DNA from
iPSC line AD2–4 by PCR ampliﬁcation and Sanger sequencing of exon 2
as described in (Cuyvers et al., 2014; Schröter et al., 2016b).
RNA-based microarray analysis
RNA-based microarray analysis was performed as described in
(Schröter et al., 2016b; Schröter et al., 2016a). Microarray analysis was
outsourced to the Genomics/Transcriptomic Laboratory of the BMFZ,
Heinrich-Heine-University, Düsseldorf.
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